Nucleic Acid Therapeutics · 2018 · 34 citations · 56 references
Life SciencesImmunologyNeuroscienceGene ExpressionInnate ImmunityNeuroimmunologyNeuroinflammationNeuroprotectionRna Interference2'-O-methoxyethyl Oligonucleotides2'-O-methyl Modification2'-O-methyl OligonucleotidesImmune Response AssessmentImmune System ModulationOligonucleotide TherapeuticsRna Interference TherapeuticsTherapy Tolerability
Antisense oligonucleotides (AONs) are versatile molecules that can be used to modulate gene expression by binding to RNA. The therapeutic potential of AONs appears particularly high in the central nervous system, due to excellent distribution and uptake in brain cells, as well as good tolerability in clinical trials thus far. Nonetheless, immune stimulation in response to AON treatment in the brain remains a concern. For this reason we performed RNA sequencing analysis of brain tissue from mice treated intracerebroventricularly with phosphorothioate, 2'-O-methyl modified AONs. A significant upregulation of immune system associated genes was observed in brains of AON treated mice, with the striatum showing largest transcriptional changes. Strongest upregulation was seen for the antiviral enzyme 2'-5'-oligoadenylate synthase-like protein 2 (Oasl2) and Bone marrow stromal antigen 2 (Bst2). Histological analysis confirmed activation of microglia and astrocytes in striatum. The upregulation of immune system associated genes was detectable for at least 2 months after the last AON administration, consistent with a continuous immune response to the AON.
56
Basic local alignment search tool
Stephen F. Altschul, Warren Gish, Webb Miller et al. · Journal of Molecular Biology · 1990 · 94.5K citations
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow, Kevin A. Guttenplan, Laura Clarke et al. · Nature · 2017 · 8K citations · Full text
Medicine, Neurobiology, Neuroscience +14